首页> 外文期刊>Implementation Science >Impact of a tailored program on the implementation of evidence-based recommendations for multimorbid patients with polypharmacy in primary care practices—results of a cluster-randomized controlled trial
【24h】

Impact of a tailored program on the implementation of evidence-based recommendations for multimorbid patients with polypharmacy in primary care practices—results of a cluster-randomized controlled trial

机译:量身定制的计划对多病态多药患者在基层医疗实践中实施循证推荐产生的影响-一项集群随机对照试验的结果

获取原文
获取外文期刊封面目录资料

摘要

BackgroundMultimorbid patients receiving polypharmacy represent a growing population at high risk for negative health outcomes. Tailoring is an approach of systematic intervention development taking account of previously identified determinants of practice. The aim of this study was to assess the effect of a tailored program to improve the implementation of three important processes of care for this patient group: (a) structured medication counseling including brown bag reviews, (b) the use of medication lists, and (c) structured medication reviews to reduce potentially inappropriate medication. MethodsWe conducted a cluster-randomized controlled trial with a follow-up time of 9?months. Participants were general practitioners (GPs) organized in quality circles and participating in a GP-centered care contract of a German health insurance. Patients aged >50?years, suffering from at least 3 chronic diseases, receiving more than 4 drugs, and being at high risk for medication-related events according to the assessment of the treating GP were enrolled. The tailored program consisted of a workshop for GPs and health care assistants, educational materials and reminders for patients, and the elaboration of implementation action plans. The primary outcome was the change in the degree of implementation between baseline and follow-up, measured by a summary score of 10 indicators. The indicators were based on structured surveys with patients and GPs. ResultsWe analyzed the data of 21 GPs (10 - intervention group, 11 - control group) and 273 patients (130 - intervention group, 143 - control group). The increase in the degree of implementation was 4.2 percentage points (95% confidence interval: ?0.3, 8.6) higher in the intervention group compared to the control group ( p =?0.1). Two of the 10 indicators were significantly improved in the intervention group: medication counseling ( p =?0.017) and brown bag review ( p =?0.012). Secondary outcomes showed an effect on patients’ self-reported use of medication lists when buying drugs in the pharmacy ( p =?0.03). ConclusionsThe tailored program may improve implementation of medication counseling and brown bag review whereas the use of medication lists and medication reviews did not improve. No effect of the tailored program on the combined primary outcome could be substantiated. Due to limitations of the study, results have to be interpreted carefully. The factors facilitating and hindering successful implementation will be examined in a comprehensive process evaluation. Trial registration number ISRCTN34664024 , assigned 14/08/2013
机译:背景接受多药治疗的多病态患者代表了不断增长的处于不利健康结果的高风险人群。量身定制是一种系统开发干预措施的方法,其中要考虑到先前确定的实践决定因素。这项研究的目的是评估定制计划的效果,以改善针对该患者组的三个重要护理过程的实施:(a)结构化的药物咨询,包括棕色袋子的审查,(b)药物清单的使用,以及(c)有组织的药物审查,以减少潜在的不适当药物。方法我们进行了一项整群随机对照试验,随访时间为9个月。参加者是在质量圈子内组织的全科医生(General GP),并参加了以德国医疗保险为中心的以GP为中心的护理合同。根据治疗GP的评估,纳入年龄大于50岁,至少患有3种慢性疾病,接受4种以上药物且发生药物相关事件的高风险的患者。量身定制的计划包括为全科医生和保健助手举办的讲习班,针对患者的教育材料和提醒,以及详细的实施行动计划。主要结果是基线和随访之间实施程度的变化,该变化由10个指标的总分衡量。指标基于对患者和全科医生的结构性调查。结果我们分析了21名GPs(10个干预组,11个对照组)和273例患者(130个干预组,143个对照组)的数据。与对照组相比,干预组的实施程度提高了4.2个百分点(95%置信区间:?0.3、8.6)(p =?0.1)。干预组的10项指标中有两项显着改善:用药咨询(p =?0.017)和皮包检查(p =?0.012)。次要结果显示,在药房购买药物时,会对患者自我报告的药物清单使用产生影响(p =?0.03)。结论量身定制的计划可能会改善药物咨询和棕色袋子审查的实施,而药物清单和药物审查的使用并没有改善。无法确定量身定制的计划对合并后的主要结局的影响。由于研究的局限性,必须仔细解释结果。在全面的过程评估中将探讨促进和阻碍成功实施的因素。试用注册号ISRCTN34664024,2013年8月14日分配

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号